These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8377026)

  • 1. Binding and channeling of alternative substrates in the enzyme DmpFG: a molecular dynamics study.
    Smith NE; Vrielink A; Attwood PV; Corry B
    Biophys J; 2014 Apr; 106(8):1681-90. PubMed ID: 24739167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and substrate recognition--a computational approach applied to HIV protease.
    Vinkers HM; de Jonge MR; Daeyaert ED; Heeres J; Koymans LM; van Lenthe JH; Lewi PJ; Timmerman H; Janssen PA
    J Comput Aided Mol Des; 2003 Sep; 17(9):567-81. PubMed ID: 14713189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scoring functions: a view from the bench.
    Tame JR
    J Comput Aided Mol Des; 1999 Mar; 13(2):99-108. PubMed ID: 10091117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.
    Lin J; Toscano PJ; Welch JT
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14020-4. PubMed ID: 9826645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of three approximate free energy calculations methods to structure based ligand design: trypsin and its complex with inhibitors.
    Radmer RJ; Kollman PA
    J Comput Aided Mol Des; 1998 May; 12(3):215-27. PubMed ID: 9749366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of solvation and binding free energy differences between VX-478 and its analogs by free energy perturbation and AMSOL methods.
    Rao BG; Kim EE; Murcko MA
    J Comput Aided Mol Des; 1996 Feb; 10(1):23-30. PubMed ID: 8786412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kynostatin (KNI)-272--a rationally designed tripeptide inhibitor of HIV protease].
    Kiso Y
    Nihon Rinsho; 1993 Sep; 51 Suppl():139-45. PubMed ID: 8271377
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of molecular dynamics and free energy perturbation calculations in anti-human immunodeficiency virus drug design.
    McCarrick MA; Kollman P
    Methods Enzymol; 1994; 241():370-84. PubMed ID: 7854189
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptide mimetics as enzyme inhibitors: use of free energy perturbation calculations to evaluate isosteric replacement for amide bonds in a potent HIV protease inhibitor.
    Cieplak P; Kollman PA
    J Comput Aided Mol Des; 1993 Jun; 7(3):291-304. PubMed ID: 8377026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative differences in the binding free energies of human immunodeficiency virus 1 protease inhibitors: a thermodynamic cycle-perturbation approach.
    Reddy MR; Viswanadhan VN; Weinstein JN
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10287-91. PubMed ID: 1946447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine.
    Baldwin ET; Bhat TN; Gulnik S; Liu B; Topol IA; Kiso Y; Mimoto T; Mitsuya H; Erickson JW
    Structure; 1995 Jun; 3(6):581-90. PubMed ID: 8590019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New hydroxyethylamine HIV protease inhibitors that suppress viral replication.
    Rich DH; Prasad JV; Sun CQ; Green J; Mueller R; Houseman K; MacKenzie D; Malkovsky M
    J Med Chem; 1992 Oct; 35(21):3803-12. PubMed ID: 1433192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors.
    Narendra Babu SN; Rangappa KS
    Bioorg Med Chem; 2008 Jan; 16(2):874-80. PubMed ID: 17981043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waterlogged molecules.
    Wolfenden R
    Science; 1983 Dec; 222(4628):1087-93. PubMed ID: 6359416
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.